Literature DB >> 4208895

Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

C H O'Callaghan, A Morris, S M Kirby, A H Shingler.   

Abstract

A new cephalosporin with a highly reactive beta-lactam ring was found to give an immediate color change in the presence of beta-lactamases from many bacteria, including staphylococci, Bacillus species, Enterobacteriaceae, and Pseudomonas. The reaction is confined to organisms producing beta-lactamases, but it is sufficiently sensitive to indicate the presence of this enzyme is small amounts in strains previously considered not to produce it. The compound has an unusual ultraviolet spectrum, and the color change can be followed quantitatively by measuring changes in absorption which occur in the 380- to 500-nm region, where cephalosporins normally have no absorption. The development of color is thought to be a consequence of the beta-lactam ring being unusually highly conjugated with the 3-substituent. Although in the bacteria only beta-lactamases produce this color change, it was found that serum and tissues from experimental animals also rapidly produced the colored breakdown product, which was then excreted in the urine. The mechanism of the mammalian breakdown was considered to be different from that found in bacteria.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4208895      PMCID: PMC444209          DOI: 10.1128/AAC.1.4.283

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Comparative amino acid contents of purified beta-lactamases from enteric bacteria.

Authors:  G W. Jack; M H. Richmond
Journal:  FEBS Lett       Date:  1970-12-23       Impact factor: 4.124

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Some cephalosporins in clinical use and their structure-activity relationships.

Authors:  C H O'Callaghan; S M Kirby
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

4.  Chemical structure of bacterial penicillinases.

Authors:  R P Ambler; R J Meadway
Journal:  Nature       Date:  1969-04-05       Impact factor: 49.962

5.  [Dynamics of beta-lactamase-like activity of the kidneys of albino mice under conditions of staphylococcal infection and the action of penicillins].

Authors:  D P Shraer; O D Simonova
Journal:  Antibiotiki       Date:  1970-03

6.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

7.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins.

Authors:  C H O'Callaghan; P W Muggleton; G W Ross
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative.

Authors:  F Knüsel; E A Konopka; J Gelzer; A Rosselet
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.

Authors:  L D Sabath; M Jago; E P Abraham
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

10.  The estimation of penicillins and penicillin destruction.

Authors:  J M HAMILTON-MILLER; J T SMITH; R KNOX
Journal:  J Pharm Pharmacol       Date:  1963-02       Impact factor: 3.765

View more
  766 in total

1.  Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.

Authors:  C A Ison; I M Martin
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

2.  Interference with murein turnover has no effect on growth but reduces beta-lactamase induction in Escherichia coli.

Authors:  A R Kraft; J Prabhu; A Ursinus; J V Höltje
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Molecular characterization of the SHV-11 beta-lactamase of Shigella dysenteriae.

Authors:  J Ahamed; M Kundu
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  Role and mechanism of action of C. PvuII, a regulatory protein conserved among restriction-modification systems.

Authors:  R M Vijesurier; L Carlock; R M Blumenthal; J C Dunbar
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

6.  New method for detecting in vitro inactivation of penicillins by Haemophilus influenzae and Staphlycoccus aureus.

Authors:  W S Lee; L Komarmy
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA.

Authors:  Thanh Luong; Subrata Sau; Marisa Gomez; Jean C Lee; Chia Y Lee
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  A new method of colorimetric assay of beta-lactamase suitable for estimation of beta-lactamase inhibition in crude microbial culture filtrates.

Authors:  M Basu; A K Sanyal; A B Banerjee
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.

Authors:  C C Sanders; M Peyret; E S Moland; S J Cavalieri; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

10.  CENTA as a chromogenic substrate for studying beta-lactamases.

Authors:  C Bebrone; C Moali; F Mahy; S Rival; J D Docquier; G M Rossolini; J Fastrez; R F Pratt; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.